Literature DB >> 15500871

Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story.

A E Tattersfield1, Ian P Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15500871     DOI： 10.1016/S0140-6736(04)17286-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The pharmacogenetics of asthma treatment.

Authors:  Kelan Tantisira; Scott Weiss
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 2.  Pharmacotherapy of critical asthma syndrome: current and emerging therapies.

Authors:  T E Albertson; M Schivo; N Gidwani; N J Kenyon; M E Sutter; A L Chan; S Louie
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

3.  Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.

Authors:  Luda Diatchenko; Amy D Anderson; Gary D Slade; Roger B Fillingim; Svetlana A Shabalina; Tomas J Higgins; Swetha Sama; Inna Belfer; David Goldman; Mitchell B Max; Bruce S Weir; William Maixner
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

4.  Beta-2-adrenergic receptor polymorphisms in cystic fibrosis.

Authors:  Wendy K Steagall; Bethany J Barrow; Connie G Glasgow; Jennifer Woo Mendoza; Mary Ehrmantraut; Jing-Ping Lin; Paul A Insel; Joel Moss
Journal:  Pharmacogenet Genomics       Date:  2007-06       Impact factor: 2.089
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.